Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
Repligen Corp (NASDAQ: RGEN) closed the day trading at $124.35 down -1.81% from the previous closing price of $126.64. In other words, the price has decreased by -$1.81 from its previous closing price. On the day, 0.57 million shares were traded. RGEN stock price reached its highest trading level at $128.0 during the session, while it also had its lowest trading level at $124.19.
Ratios:
For a better understanding of RGEN, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.87 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 66.03. For the most recent quarter (mrq), Quick Ratio is recorded 7.32 and its Current Ratio is at 8.59. In the meantime, Its Debt-to-Equity ratio is 0.33 whereas as Long-Term Debt/Eq ratio is at 0.32.
On June 24, 2025, Barclays started tracking the stock assigning a Overweight rating and target price of $150.
Wolfe Research Upgraded its Peer Perform to Outperform on April 29, 2025, while the target price for the stock was maintained at $160.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 08 ’25 when Madaus Martin D bought 1,800 shares for $112.13 per share. The transaction valued at 201,830 led to the insider holds 1,800 shares of the business.
Hunt Anthony sold 26,447 shares of RGEN for $3,271,688 on May 15 ’25. The Director now owns 109,854 shares after completing the transaction at $123.71 per share. On May 15 ’25, another insider, Hunt Anthony, who serves as the Director of the company, bought 26,447 shares for $128.34 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RGEN now has a Market Capitalization of 6995351552 and an Enterprise Value of 6972562432. For the stock, the TTM Price-to-Sale (P/S) ratio is 10.38 while its Price-to-Book (P/B) ratio in mrq is 3.39. Its current Enterprise Value per Revenue stands at 10.346 whereas that against EBITDA is 55.138.
Stock Price History:
The Beta on a monthly basis for RGEN is 1.07, which has changed by -0.19158757 over the last 52 weeks, in comparison to a change of 0.15005577 over the same period for the S&P500. Over the past 52 weeks, RGEN has reached a high of $182.52, while it has fallen to a 52-week low of $102.96. The 50-Day Moving Average of the stock is 1.34%, while the 200-Day Moving Average is calculated to be -10.03%.
Shares Statistics:
Over the past 3-months, RGEN traded about 828.38K shares per day on average, while over the past 10 days, RGEN traded about 771630 shares per day. A total of 56.25M shares are outstanding, with a floating share count of 53.18M. Insiders hold about 5.46% of the company’s shares, while institutions hold 103.15% stake in the company. Shares short for RGEN as of 1753920000 were 3636755 with a Short Ratio of 4.39, compared to 1751241600 on 3765995. Therefore, it implies a Short% of Shares Outstanding of 3636755 and a Short% of Float of 8.72.
